Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes
de Vries, Marieke; Westerink, Jan; El-Morabit, Fatima; Kaasjager, H. A.H.(Karin); de Valk, Harold W.
(2022) Diabetes Research and Clinical Practice, volume 186, pp. 1 - 7
(Article)
Abstract
Aims: Assess prevalence of hepatic steatosis (HS) and of fibrosis in an unselected population of patients with type 1 diabetes. Describe their clinical profile and explore the association between insulin resistance and NAFLD as secondary objectives. Methods: We prospectively assessed NAFLD by transient elastography in adult outpatients with type 1
... read more
diabetes. Patients were eligible if they did not have any known secondary cause of liver disease. NAFLD was defined as HS with or without fibrosis/cirrhosis. Associations between estimated glucose disposal rate (eGDR) and metabolic syndrome, as surrogate markers of insulin resistance, and NAFLD were explored using multivariate logistic regression models, adjusting for age, sex and diabetes duration. Results: We enrolled 150 consecutive subjects (age 47 ± 14 years, male 55%, diabetes duration 25 ± 14 years, median BMI 25 kg/m2). NAFLD prevalence was 20% (n = 30). Thirty patients (20%) had HS. Five patients (3.3%) had HS with fibrosis. eGDR and metabolic syndrome were statistically significantly associated with the presence of NAFLD (OR 0.62, 95% CI 0.49–0.77, OR 7.62, 95% CI 2.95–19.77). Conclusions: NAFLD prevalence in patients with type 1 diabetes is considerable, mainly restricted to isolated HS, while fibrosis is rare. Insulin resistance is associated with NAFLD in patients with type 1 diabetes.
show less
Download/Full Text
Keywords: Fibrosis, Insulin resistance, NAFLD, Non-alcoholic fatty liver disease, Transient elastography, Type 1 diabetes, Prevalence, Humans, Middle Aged, Insulin Resistance, Male, Metabolic Syndrome/complications, Diabetes Mellitus, Type 1/complications, Liver Cirrhosis/epidemiology, Biomarkers, Adult, Non-alcoholic Fatty Liver Disease/complications, Endocrinology, Internal Medicine, Endocrinology, Diabetes and Metabolism, Journal Article
ISSN: 0168-8227
Publisher: Elsevier Ireland Ltd
Note: Funding Information: The authors thank the study participants and K.E. van Erpecum, MD PhD, gastroenterologist, for providing the use of transient elastography. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. Publisher Copyright: © 2022 The Authors
(Peer reviewed)